title: Confronting the chronically anticoagulated, acute care surgery patient as we evolve into the post-warfarin era.
abstract: There are a growing number of new anticoagulants used as an alternative to warfarin. Surgeons will be confronted with an increasing number of patients who may be on these outpatient medications and must be familiar with their management strategies. The purpose of this review is to examine the mechanisms, monitoring and therapeutic reversal of the non-warfarin antithrombotic agents now so frequently confronting the acute care surgeon.
authors.affiliation: Department of Surgery, University of California, San Francisco-East Bay, Alameda County Medical Center, Oakland, CA 94602, USA. lyeung@acmedctr.org
authors.forename: Louise
authors.initials: L
authors.lastname: Yeung
authors.forename: Emily
authors.initials: E
authors.lastname: Miraflor
authors.forename: Alden
authors.initials: A
authors.lastname: Harken
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000991:Antithrombins / Q000494:pharmacology; D001281:Atrial Fibrillation / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects; D065427:Factor Xa Inhibitors; D006801:Humans; D019990:Perioperative Care / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D014859:Warfarin / Q000009:adverse effects
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin